Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Johnson & Johnson'
Title Publication Date Price Relevance
Johnson & Johnson
Strategic Analysis Profile
 Feb 2008 £500 100%
Johnson & Johnson Inc Feb 2006 £195 99%
Johnson & Johnson: Corporate Analysis May 2008 £255 99%
Johnson & Johnson-Therapeutic Competitors Mar 2011 £220 99%
Johnson and Johnson - SWOT Framework Analysis Jan 2011 £63 99%
Johnson & Johnson-Detailed Product Pipeline Mar 2011 £475 99%
IMS Company Profiles:Johnson & Johnson May 2011 £640 99%
Pharma Company Profiles - Johnson and Johnson Oct 2008 £255 99%
Johnson & Johnson Inc: OTC Healthcare Jan 2007 £195 99%
Johnson Controls: Corporate Analysis May 2008 £255 99%
Johnson & Johnson Product Pipeline Analysis Jan 2009 £475 99%
Johnson & Johnson: Strategic Analysis Profile Feb 2008 £500 99%
Johnson & Johnson to Acquire Synthes
Betting Big on the Orthopedic Devices Market Opportunity
 Apr 2011 £315 99%
Johnson & Johnson: Pharma Growth Strategy
How does the world's 7th largest pharma company plan to grow its pharmaceutical revenues?
 Jul 2009 £245 98%
Deal Making Spotlight on Johnson & Johnson
Spotlight Report Series
 Apr 2006 £630 98%
Johnson & Johnson Vision Care, Inc. Medical Equipment Company Report Mar 2008 £630 98%
Johnson & Johnson-Deals & Alliances Report Mar 2011 £380 98%
Johnson & Johnson Vision Care, Inc: Market Share Analysis Nov 2009 £630 98%
Partnering Agreements with Johnson & Johnson
2010
 Jan 2010 £630 98%
Johnson & Johnson Pharmaceutical Research & Development, LLC-Deals & Alliances Report Mar 2011 £380 97%
Johnson & Johnson (JNJ)
Financial and Strategic SWOT Analysis Review
 Dec 2011 £79 97%
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. - Product Pipeline Review
Q4 2010
 Nov 2010 £315 97%
Johnson & Johnson to Acquire Mentor Corporation: Expanding Presence in the Aesthetic Devices Market Dec 2008 £315 97%
OTC Pharmaceuticals - Scandinavia Industry Guide Nov 2010 £505 94%
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Nov 2010 £630 94%
OTC Pharmaceuticals - North America (NAFTA) Industry Guide Nov 2010 £505 94%
Pharmaceuticals in Canada Jan 2011 £160 94%
OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide Nov 2010 £630 93%
Pharmaceuticals in Sweden Jan 2011 £160 93%
Global OTC Pharmaceuticals Nov 2010 £160 93%